Page last updated: 2024-08-23

plicamycin and Parkinson Disease

plicamycin has been researched along with Parkinson Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, X; Huang, B; Ye, Q; Zhang, X; Zhu, Y	1

Other Studies

1 other study(ies) available for plicamycin and Parkinson Disease

Article	Year
Astaxanthin suppresses MPP(+)-induced oxidative damage in PC12 cells through a Sp1/NR1 signaling pathway. Marine drugs, 2013, Mar-28, Volume: 11, Issue:4 Topics: 1-Methyl-4-phenylpyridinium; Animals; Blotting, Western; Fluorescent Antibody Technique; Neuroprotective Agents; Oxidative Stress; Parkinson Disease; PC12 Cells; Plicamycin; Rats; Real-Time Polymerase Chain Reaction; Receptors, N-Methyl-D-Aspartate; RNA, Messenger; Signal Transduction; Sp1 Transcription Factor; Xanthophylls	2013

Article

Year

Astaxanthin suppresses MPP(+)-induced oxidative damage in PC12 cells through a Sp1/NR1 signaling pathway.

Marine drugs, 2013, Mar-28, Volume: 11, Issue:4

Topics: 1-Methyl-4-phenylpyridinium; Animals; Blotting, Western; Fluorescent Antibody Technique; Neuroprotective Agents; Oxidative Stress; Parkinson Disease; PC12 Cells; Plicamycin; Rats; Real-Time Polymerase Chain Reaction; Receptors, N-Methyl-D-Aspartate; RNA, Messenger; Signal Transduction; Sp1 Transcription Factor; Xanthophylls

2013